CHING-WEI DAVID TZENG to Radiotherapy, Adjuvant
This is a "connection" page, showing publications CHING-WEI DAVID TZENG has written about Radiotherapy, Adjuvant.
Connection Strength
0.272
-
Effect of complications on oncologic outcomes after pancreaticoduodenectomy for pancreatic cancer. J Surg Res. 2017 06 15; 214:1-8.
Score: 0.100
-
Yield of clinical and radiographic surveillance in patients with resected pancreatic adenocarcinoma following multimodal therapy. HPB (Oxford). 2012 Jun; 14(6):365-72.
Score: 0.071
-
Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer. 2006 Jul 15; 107(2):371-9.
Score: 0.048
-
Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford). 2014 Apr; 16(4):350-6.
Score: 0.020
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.019
-
Retroperitoneal and intra-abdominal sarcoma. Curr Probl Surg. 2009 Jun; 46(6):445-503.
Score: 0.015